First Time Loading...

Cumberland Pharmaceuticals Inc
NASDAQ:CPIX

Watchlist Manager
Cumberland Pharmaceuticals Inc Logo
Cumberland Pharmaceuticals Inc
NASDAQ:CPIX
Watchlist
Price: 1.54 USD -11.49% Market Closed
Updated: May 13, 2024

Gross Margin
Cumberland Pharmaceuticals Inc

84.7%
Current
80%
Average
49%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
84.7%
=
Gross Profit
33.5m
/
Revenue
39.6m

Gross Margin Across Competitors

Country US
Market Cap 21.7m USD
Gross Margin
85%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 722.3B USD
Gross Margin
80%
Country DK
Market Cap 4T DKK
Gross Margin
85%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country US
Market Cap 360.8B USD
Gross Margin
70%
Country US
Market Cap 329.4B USD
Gross Margin
75%
Country UK
Market Cap 191.1B GBP
Gross Margin
82%
Country CH
Market Cap 181.1B CHF
Gross Margin
74%
Country CH
Market Cap 180B CHF
Gross Margin
73%
Country US
Market Cap 158.1B USD
Gross Margin
70%

Profitability Report

View the profitability report to see the full profitability analysis for Cumberland Pharmaceuticals Inc.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
84.7%
=
Gross Profit
33.5m
/
Revenue
39.6m
What is the Gross Margin of Cumberland Pharmaceuticals Inc?

Based on Cumberland Pharmaceuticals Inc's most recent financial statements, the company has Gross Margin of 84.7%.